Se prevé que el mercado de nutrición médica enteral alcance los 11.726,37 millones de dólares en 2028, frente a los 7.803,45 millones de dólares de 2021; se espera que crezca a una tasa compuesta anual del 6,0 % de 2022 a 2028.
La nutrición enteral (NE) se proporciona a pacientes cuyas necesidades energéticas y nutricionales no pueden satisfacerse con una ingesta regular de alimentos. Las ventajas de la ingesta enteral sobre la nutrición parenteral son bien reconocidas. Para la mayoría de los pacientes pediátricos que dependen de la nutrición enteral, una fórmula polimérica estándar adaptada a la edad enriquecida con fibras es una opción adecuada.
El mercado de nutrición médica enteral está segmentado según la indicación, el tipo de nutrición y la forma. , producto, canal de distribución, grupo de edad y geografía. Por geografía, el mercado está ampliamente segmentado en América del Norte, Europa, Asia Pacífico, Medio Oriente y Asia. África y el Sur y el Sur. Centroamérica. El informe ofrece información y un análisis en profundidad del mercado, enfatizando parámetros como las tendencias y la dinámica del mercado, y el análisis competitivo de los principales actores del mercado a nivel mundial.
Perspectivas estratégicas
Regiones lucrativas para el mercado de nutrición médica enteral
Perspectivas del mercado
Aumento de la prevalencia de caquexia
La caquexia es una enfermedad multifuncional que causa una pérdida extrema de peso, pérdida de músculo esquelético y tejido adiposo, desequilibrio de la regulación metabólica y reducción de la ingesta de alimentos. Es una consecuencia clínica grave de casi todas las enfermedades crónicas cuando alcanzan estadios avanzados. Según el NCBI (Centro Nacional de Información Biotecnológica), en 2016, la prevalencia de caquexia osciló entre el 5 y el 15% en la insuficiencia cardíaca crónica terminal. Ocurre con frecuencia en pacientes que padecen enfermedad renal crónica, enfermedad pulmonar obstructiva crónica (EPOC), enfermedades neurológicas y artritis reumatoide. Las tasas de mortalidad de los pacientes con caquexia oscilan entre el 15 y el 25 % anual en pacientes con EPOC grave y del 20 al 40 % anual en pacientes con insuficiencia cardíaca crónica o enfermedad renal crónica.
La caquexia por cáncer afecta negativamente a la calidad de vida de los pacientes con cáncer, reduce la eficacia de la quimioterapia anticancerígena y aumenta su toxicidad, lo que conduce a un aumento de la mortalidad relacionada con el cáncer y del gasto en recursos médicos. Según Globocan, la Organización Mundial de la Salud informó de 9,6 millones de muertes y 18,1 millones de nuevos casos de cáncer en 2018. Además, la caquexia por cáncer es un síndrome de emaciación que ocurre hasta en el 80% de los pacientes con cáncer. Según el artículo publicado por el Departamento de Medicina Pulmonar y de Cuidados Críticos de Beijing, la prevalencia de caquexia es del 87% en pacientes con cáncer de páncreas y gástrico; 61% en pacientes con cáncer de colon, pulmón y próstata; y ~40% en pacientes con cáncer de mama, sarcoma, leucemia y linfoma de Hodgkin. Además, el 20% del total de muertes relacionadas con el cáncer se deben a la caquexia. En la caquexia, los nutrientes del cuerpo disminuyen. Por tanto, es necesario aportar nutrientes externos para continuar el tratamiento del cáncer y la EPOC. Los médicos prefieren la vía enteral para proporcionar estos nutrientes necesarios al paciente. Por lo tanto, la creciente prevalencia de caquexia debido a la creciente incidencia de diversas enfermedades crónicas impulsa el crecimiento del mercado de nutrición médica enteral.
Información sobre indicaciones
Basado en la indicación, la medicina enteral El mercado de nutrición se segmenta en trastornos respiratorios, cáncer, post COVID-19, trastornos gastrointestinales, insuficiencia hepática y otros. El mercado para el segmento de trastornos respiratorios se segmenta aún más en enfermedad pulmonar obstructiva crónica (EPOC), insuficiencia respiratoria, fibrosis quística y otras. El mercado para el segmento del cáncer se subsegmenta en caquexia por cáncer, caquexia con EPOC y otros. El mercado para el segmento de trastornos gastrointestinales se segmenta aún más en obstrucción intestinal, obstrucción del intestino corto, enfermedad de Crohn y otras. El segmento de trastornos respiratorios tuvo la mayor participación de mercado en 2021. Sin embargo, se prevé que el segmento de cáncer registre la CAGR más alta del mercado del 7,6% durante el período de pronóstico. Pulmocare fabricado por Abbott está diseñado para personas que padecen EPOC, fibrosis quística o insuficiencia respiratoria. La fórmula enteral rica en calorías y con carbohidratos y grasas modificados puede ayudar a estos pacientes a reducir la producción de dióxido de carbono inducida por la dieta.
Mercado de nutrición médica enteral, por indicación: 2022 y 2028
Información sobre el tipo de nutrición
Según el tipo de nutrición, el mercado mundial de nutrición médica enteral se divide en suplementario y de fuente única. El segmento complementario tuvo una mayor participación de mercado en 2021. Sin embargo, se prevé que el segmento de fuente única registre una CAGR más alta durante el período de pronóstico. Los pacientes que reciben la fuente suplementaria de nutrición están sujetos a permanecer hospitalizados por un período prolongado. Se proporcionan a los pacientes fórmulas enterales enriquecidas en ácidos grasos omega-3, ácidos ribonucleicos y glutamina o arginina. Por ejemplo, Jevity es una fórmula nutricional diseñada para proporcionar nutrición suplementaria o de fuente única a adultos que siguen regímenes de alimentación por sonda a corto o largo plazo. El mismo está disponible en densidades calóricas de 1,0, 1,2 y 1,5 calorías por mililitro. Las fórmulas de Jevity también pueden ayudar a satisfacer las necesidades de los pacientes. necesidades diarias de proteínas y fibra.
Form Insights
Según la forma, el mercado mundial de nutrición médica enteral se segmenta en polvo, líquido y semisólido. El segmento semisólido tuvo la mayor participación de mercado en 2021 y se prevé que registre la CAGR más alta durante el período de pronóstico.
Información sobre el producto
Según el producto, la nutrición médica enteral global El mercado se segmenta en dieta proteica estándar, dieta alta en proteínas, nutrientes orales a base de jugo de frutas y otros. El segmento de dieta proteica estándar tuvo la mayor participación del mercado en 2021. Sin embargo, se anticipa que el segmento de nutrientes orales a base de jugos de frutas registre la CAGR más alta durante el período de pronóstico.
Información del canal de distribución
Según el canal de distribución, el mercado de nutrición médica enteral se segmenta en farmacias hospitalarias, tiendas minoristas y otras farmacias. El segmento de farmacias hospitalarias tuvo la mayor participación del mercado en 2021. Sin embargo, se anticipa que el segmento de tiendas minoristas registre la CAGR más alta durante el período de pronóstico.
Age Group Insights
Basado en Según la edad, el mercado de nutrición médica enteral se divide en niños (hasta 18 años) y adultos (más de 18 años). El adulto (más de 18 años) tuvo una mayor participación de mercado en 2021. Sin embargo, se prevé que el segmento infantil (hasta 18 años) registre una CAGR más alta durante el período de pronóstico.
Mercado de Nutrición Médica Enteral - por región
Por geografía, el mercado global está segmentado en América del Norte (EE. UU., Canadá y México), Europa (Reino Unido, Alemania, Francia, Italia, España y el resto de Europa), Asia Pacífico (China, Japón, India, Australia, Corea del Sur y el resto de Asia Pacífico), Medio Oriente y Asia. África (Emiratos Árabes Unidos, Arabia Saudita, Sudáfrica y el resto de Medio Oriente y África) y Sur y África. Centroamérica (Brasil, Argentina y el resto de Centro y Suramérica).
Perfiles de empresas
Abbott Laboratories; Nutricia; Fresenius Kabi AG; B. Braun Melsungen AG; NESTLÉ SA; Meiji Holdings Co., Ltd.; Pez inteligente AS; DSM; Corporación de Alimentos Hormel; y Global Health Products, Inc. se encuentran entre los principales actores del mercado de nutrición médica enteral.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Enteral nutrition refers to any method of feeding that uses the gastrointestinal (GI) tract to deliver nutrition and calories. It can include a normal oral diet, the use of liquid supplements, or delivery by use of a tube (tube feeding). According to the American College of Gastroenterology, there are six main types of feeding tubes. These tubes may have further subtypes depending on exactly where they end in the stomach or intestines.
Factors such as the prevalence of cachexia and the rise in the prevalence of gastrointestinal diseases drive the market growth. However, the complications associated with enteral medical nutrition hamper the growth of the market.
The enteral medical nutrition market majorly consists of the players such as Abbott Laboratories; Nutricia; Fresenius Kabi AG; B. Braun Melsungen AG; NESTLE S.A.; Meiji Holdings Co., Ltd.; Smartfish AS; DSM; Hormel Foods Corporation; and Global Health Products, Inc.
The global enteral medical nutrition market based on indication, is segmented into respiratory disorders, cancer, post COVID-19, gastrointestinal disorders, liver failure, others. The respiratory disorders segment held the largest share of the market in 2021. However, the cancer segment is expected to register the highest CAGR during the forecast period.
The List of Companies - Enteral Medical Nutrition Market
- Abbott Laboratories
- Nutricia
- Fresenius Kabi AG
- B. Braun Melsungen AG
- NESTLE S.A.
- Meiji Holdings Co., Ltd.
- Smartfish AS
- DSM
- Hormel Foods Corporation
- Global Health Products, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Aug 2022
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Aug 2022
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Aug 2022
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Aug 2022
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Aug 2022
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Aug 2022
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)